Newly Reported Substances: The following substances were reported to NFLIS-Drug for the first time between April 1, 2022, and...
Reports
A Panel Study of the Effect of Cannabis Use on Mental Health, Depression and Suicide in the 50 States
Lisa McElhaney / /A first of its kind nationwide study, commissioned by Drug Free America Foundation, Inc. and Johnny’s Ambassadors, finds more...
The 2022 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type...
Telehealth and Substance Use Disorder Services in the Era of Covid 19: Review and Recommendations
Lisa McElhaney / /On June 22, the Office of National Drug Control Policy announced the release of LAPPA’s white paper, Telehealth and...
The European Drug Report (EDR) 2022 arrives at a time when recent major global events have impacted profoundly on...
The CFSRE is developing Public Alerts and related reports to increase public awareness regarding NPS involvement in adverse intoxications,...
The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical examiners...
This report provides up-to-date informatyion regarding the drug supply in Philadelphia, PA.
Federal Register: 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) in Schedule I
Lisa McElhaney / /With the issuance of this final rule, the Drug Enforcement Administration places 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE), including its salts, isomers, and...
In 2021, the Drug Abuse Warning Network (DAWN) identified 141,529 (unweighted) drug-related emergency department (ED) visits from 52 participating...
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024